(a) Based on the 12,618,146 participants who returned a valid iFOBT.
(b) Information on colonoscopies known through MBS claim only prior to 2018 is not included; PI 3 and PI 4 may be under-reported. Count also includes colonoscopies, from 2021 onwards, that were notified through PFUF data.
(c) Based on available outcome data. Excludes 284,443 assessments with no record of outcome.
(d) Includes improved data from notifiable bowel cancer diagnoses (Australian Cancer Database), to 2021 only.
Notes:
- PI 1: ‘people participated’ counts the people who participated over the time the NBCSP has been operating. It is not a unique count of people, and people who participated multiple times over several years were counted more than once. ‘Unique people participated’ counts each unique person who has participated in the program at least once.
- Assessment and diagnosis (PIs 3–9) rely on information being reported back to the NCSR. As return of NBCSP forms is required (ACSQHC 2020) but not mandated by the NBCSP, there may be incomplete form return and incomplete data. See ‘Current reporting limitations’ for more details.
- PI 5a (adenoma detection rate), PI 5b (PPV of diagnostic assessment for detecting adenoma), and PI 8 (cancer clinico-pathological stage distribution) are not reported due to data incompleteness or unavailability. See ‘Current reporting limitations’ for more details.
Source: AIHW analysis of NCSR as at 31 December 2024 (NCSR RDE 13/01/2025).
